GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Sentry Investment Management LLC

Sentry Investment Management LLC cut its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,469 shares of the company’s stock after selling 239 shares during the period. Sentry Investment Management LLC’s holdings in GE HealthCare Technologies were worth $115,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Mengis Capital Management Inc. increased its holdings in shares of GE HealthCare Technologies by 31.7% during the fourth quarter. Mengis Capital Management Inc. now owns 44,362 shares of the company’s stock valued at $3,468,000 after purchasing an additional 10,685 shares during the period. Impax Asset Management Group plc acquired a new position in shares of GE HealthCare Technologies during the fourth quarter valued at $660,000. Skylands Capital LLC increased its holdings in shares of GE HealthCare Technologies by 19.7% during the fourth quarter. Skylands Capital LLC now owns 156,790 shares of the company’s stock valued at $12,258,000 after purchasing an additional 25,815 shares during the period. IFP Advisors Inc increased its holdings in shares of GE HealthCare Technologies by 15.1% during the fourth quarter. IFP Advisors Inc now owns 2,743 shares of the company’s stock valued at $215,000 after purchasing an additional 360 shares during the period. Finally, Waverton Investment Management Ltd acquired a new position in shares of GE HealthCare Technologies during the fourth quarter valued at $48,977,000. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 0.2 %

NASDAQ:GEHC opened at $90.67 on Thursday. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The firm has a market capitalization of $41.46 billion, a price-to-earnings ratio of 20.94, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The stock has a fifty day simple moving average of $85.76 and a 200 day simple moving average of $86.05.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have recently commented on GEHC shares. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Finally, Citigroup lifted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.